Artivion Executive and Leadership Team

Tara Riva, the Executive Assistant To Pat Mackin, Chairman, President and Chief Executive Officer at Artivion, manages complex scheduling and communication workflows for the executive office. Riva coordinates high-level interactions between the leadership team and external stakeholders to ensure operational efficiency. By streamlining administrative processes, the Executive Assistant To Pat Mackin, Chairman, President and Chief Executive Officer facilitates seamless decision-making across the organization. This role involves prioritizing critical business inquiries and maintaining alignment with the strategic goals of the company. Through meticulous organization, Riva supports the executive leadership in navigating the global medical technology landscape. The Executive Assistant To Pat Mackin, Chairman, President and Chief Executive Officer maintains rigorous standards for corporate governance and internal communication. By optimizing the daily operations of the office, Riva enables the leadership team to focus on developing innovative solutions for aortic disease treatment and expanding the reach of medical technologies.

Lance Berry, the Executive Vice President & Chief Operating Officer & Chief Financial Officer at Artivion, directs the financial health and operational infrastructure of the organization. Berry oversees global supply chain logistics and capital allocation strategies to support the manufacturing of cardiac and vascular devices. By integrating financial planning with operational execution, the Executive Vice President & Chief Operating Officer & Chief Financial Officer drives sustainable growth and profitability. This leadership role involves managing fiscal reporting and optimizing internal processes to ensure the delivery of high-quality surgical sealants and stent grafts. Lance Berry monitors market trends to refine the operational scale across international regions. Through disciplined resource management, the Executive Vice President & Chief Operating Officer & Chief Financial Officer strengthens the market position of the company. Berry ensures that financial objectives align with the mission of providing advanced medical solutions to surgeons and patients, ultimately securing long-term stability for the enterprise.

Simona Zannetti, the Senior VP, Clinical Research & Chief Medical Officer at Artivion, leads the scientific validation and clinical trial programs for aortic disease treatments. Zannetti designs rigorous study protocols to demonstrate the efficacy of implantable tissues and heart valves. By collaborating with global surgical partners, the Senior VP, Clinical Research & Chief Medical Officer ensures that clinical data supports the adoption of advanced medical technologies. This role involves navigating complex regulatory environments to bring innovative devices to market. Simona Zannetti oversees the integration of medical expertise into product development cycles to enhance patient outcomes. Through the management of clinical research initiatives, the Senior VP, Clinical Research & Chief Medical Officer drives the evidence-based strategy of the company. Zannetti maintains high standards for safety and performance, ensuring that all clinical activities align with the commitment to excellence in the medical technology sector and the broader goals of the organization.

Marshall Stanton, the Senior Vice President, Clinical Research and Chief Medical Officer at Artivion, directs the strategic oversight of clinical development and medical affairs. Stanton manages the evaluation of new surgical technologies to ensure alignment with current clinical needs in aortic disease treatment. By fostering relationships with medical professionals, the Senior Vice President, Clinical Research and Chief Medical Officer facilitates the successful implementation of stent grafts and surgical sealants. This leadership role involves analyzing clinical outcomes to inform future product innovation and market expansion. Marshall Stanton coordinates with internal teams to maintain compliance with medical standards and regulatory requirements. Through the leadership of clinical research, the Senior Vice President, Clinical Research and Chief Medical Officer supports the mission of improving patient care through high-quality medical devices. Stanton ensures that the clinical strategy remains responsive to the evolving demands of the global healthcare market, driving the overall success of the company.